• 1. Evidence of rutile-to-anatase photo-induced electron transfer in mixed-phase TiO2 by solid-state NMR spectroscopy?
  Weili Dai,Guangjun Wu,Michael Hunger Chem. Commun., 2015,51, 13779-13782
• 2. Embedding heteroatoms: an effective approach to create porphyrin-based functional materials
  Norihito Fukui,Keisuke Fujimoto,Hideki Yorimitsu,Atsuhiro Osuka Dalton Trans., 2017,46, 13322-13341
• 3. Exciplex emission from the mixed dimer of naphthalene and 2-cyanonaphthalene in a supersonic jet
  Aloke Das,K. K. Mahato,Chayan K. Nandi,Tapas Chakraborty,Shridhar R. Gadre,Nikhil A. Gokhale Phys. Chem. Chem. Phys., 2002,4, 2162-2168
• 4. Emergence of cationic polyamine dendrimersomes: design, stimuli sensitivity and potential biomedical applications
  Partha Laskar,Christine Dufès Nanoscale Adv., 2021,3, 6007-6026
• 5. Fe3O4 nanoparticle chains with N-doped carbon coating: magnetotactic bacteria assisted synthesis and high-rate lithium storage?
  Dan Yang,Yanping Zhou,Xianhong Rui,Jixin Zhu,Ziyang Lu,Eileen Fong,Qingyu Yan RSC Adv., 2013,3, 14960-14962

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles Benzimidazoles
• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Benzimidazoles

Comprehensive Overview of 7-amino-1,3-dihydro-1-methyl-2H-Benzimidazol-2-one (CAS No. 851886-92-5)

7-amino-1,3-dihydro-1-methyl-2H-Benzimidazol-2-one (CAS No. 851886-92-5) is a specialized organic compound belonging to the benzimidazole class, which has garnered significant attention in pharmaceutical and biochemical research. This compound, characterized by its amino and methyl functional groups, serves as a critical intermediate in the synthesis of various bioactive molecules. Its unique structure makes it a valuable candidate for applications in drug discovery, particularly in targeting enzymes and receptors involved in metabolic pathways.

The growing interest in benzimidazole derivatives stems from their diverse pharmacological properties, including antimicrobial, antiviral, and anticancer activities. Researchers are increasingly exploring 7-amino-1,3-dihydro-1-methyl-2H-Benzimidazol-2-one for its potential role in developing novel therapeutics. For instance, its structural similarity to purine bases allows it to interact with DNA and RNA, making it a promising scaffold for designing small-molecule inhibitors. This aligns with current trends in precision medicine, where targeted therapies are in high demand.

From a synthetic chemistry perspective, the compound’s CAS No. 851886-92-5 is often referenced in patents and academic publications detailing innovative synthetic routes. Its amino group provides a reactive site for further functionalization, enabling the creation of libraries of derivatives for high-throughput screening. This is particularly relevant in the context of AI-driven drug discovery, where computational models predict the bioactivity of such compounds before laboratory validation. As a result, 7-amino-1,3-dihydro-1-methyl-2H-Benzimidazol-2-one is frequently discussed in forums focusing on cheminformatics and molecular docking studies.

Another area of interest is the compound’s potential role in green chemistry. With sustainability becoming a priority, researchers are investigating eco-friendly synthesis methods for benzimidazole derivatives. 7-amino-1,3-dihydro-1-methyl-2H-Benzimidazol-2-one can be synthesized using catalytic processes that minimize waste and reduce energy consumption, addressing the demand for sustainable pharmaceuticals. This aligns with global initiatives like the UN’s Sustainable Development Goals (SDGs), particularly Goal 12 (Responsible Consumption and Production).

In analytical chemistry, the compound’s purity and stability are critical for reproducible results. Advanced techniques such as HPLC and LC-MS are employed to characterize CAS No. 851886-92-5, ensuring compliance with regulatory standards. This is especially important for researchers sourcing the compound for preclinical studies, where consistency is paramount. Frequently asked questions (FAQs) in online forums often revolve around its solubility, storage conditions, and compatibility with common reagents.

Beyond pharmaceuticals, 7-amino-1,3-dihydro-1-methyl-2H-Benzimidazol-2-one has potential applications in material science. Its conjugated system and heterocyclic core make it a candidate for developing organic semiconductors or fluorescent probes. This versatility underscores its relevance in interdisciplinary research, bridging gaps between chemistry, biology, and engineering.

In summary, 7-amino-1,3-dihydro-1-methyl-2H-Benzimidazol-2-one (CAS No. 851886-92-5) is a multifaceted compound with broad applicability in drug development, sustainable chemistry, and advanced materials. Its integration into cutting-edge research areas like AI-augmented discovery and green synthesis highlights its enduring significance. As scientific communities continue to explore its properties, this compound is poised to remain a focal point in innovation-driven industries.

• 1849-01-0(1-Methyl-2-benzimidazolinone)
• 95-23-8(5-Amino-1,3-dihydro-2H-benzimidazol-2-one)
• 3097-21-0(1,3-Dimethyl-1,3-dihydro-2H-benzimidazol-2-one)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)